These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15238239)

  • 1. The dioxin TCDD protects against aflatoxin-induced mutation in female rats, but not in male rats.
    Thornton AS; Oda Y; Stuart GR; Holcroft J; de Boer JG
    Mutat Res; 2004 Jul; 561(1-2):147-52. PubMed ID: 15238239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity of TCDD in Big Blue transgenic rats.
    Thornton AS; Oda Y; Stuart GR; Glickman BW; de Boer JG
    Mutat Res; 2001 Jul; 478(1-2):45-50. PubMed ID: 11406168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflatoxin B1-induced TP53 mutational pattern in normal human cells using the FASAY (Functional Analysis of Separated Alleles in Yeast).
    Paget V; Sichel F; Garon D; Lechevrel M
    Mutat Res; 2008 Oct; 656(1-2):55-61. PubMed ID: 18725321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coumarin chemoprotection against aflatoxin B1-induced gene mutation in a mammalian cell system: a species difference in mutagen activation and protection with chick embryo and rat liver S9.
    Goeger DE; Anderson KE; Hsie AW
    Environ Mol Mutagen; 1998; 32(1):64-74. PubMed ID: 9707100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aflatoxin toxicity in cultured human epidermal cells: stimulation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walsh AA; Hsieh DP; Rice RH
    Carcinogenesis; 1992 Nov; 13(11):2029-33. PubMed ID: 1423872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interspecies differences in cancer susceptibility and toxicity.
    Hengstler JG; Van der Burg B; Steinberg P; Oesch F
    Drug Metab Rev; 1999 Nov; 31(4):917-70. PubMed ID: 10575555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimutagenic activity of natural phenolic compounds present in the common bean (Phaseolus vulgaris) against aflatoxin B1.
    Cardador-Martínez A; Castaño-Tostado E; Loarca-Piña G
    Food Addit Contam; 2002 Jan; 19(1):62-9. PubMed ID: 11811767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibition of eight natural foods on mutagenic effect by aflatoxin B1 and extracts of fungi].
    Ruan CC
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 Mar; 26(2):83-5. PubMed ID: 1451583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of antimutagenic properties of vitamin E.
    Chłopkiewicz B; Marczewska J; Koziorowska J
    Acta Pol Pharm; 1991; 48(3-4):33-4. PubMed ID: 1669541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cis-Terpenones as an effective chemopreventive agent against aflatoxin B1-induced cytotoxicity and TCDD-induced P450 1A/B activity in HepG2 cells.
    Zhou Q; Xie H; Zhang L; Stewart JK; Gu XX; Ryan JJ
    Chem Res Toxicol; 2006 Nov; 19(11):1415-9. PubMed ID: 17112227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains.
    Viluksela M; Bager Y; Tuomisto JT; Scheu G; Unkila M; Pohjanvirta R; Flodström S; Kosma VM; Mäki-Paakkanen J; Vartiainen T; Klimm C; Schramm KW; Wärngård L; Tuomisto J
    Cancer Res; 2000 Dec; 60(24):6911-20. PubMed ID: 11156390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is 2,3,7,8-TCDD (dioxin) a carcinogen for humans?
    Ayres SM; Webb KB; Evans RG; Mikes J
    Environ Health Perspect; 1985 Oct; 62():329-35. PubMed ID: 3910419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against aflatoxin-B1-induced liver mutagenesis by Scutellaria baicalensis.
    de Boer JG; Quiney B; Walter PB; Thomas C; Hodgson K; Murch SJ; Saxena PK
    Mutat Res; 2005 Oct; 578(1-2):15-22. PubMed ID: 16202794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection by dietary compounds against mutation in a transgenic rodent.
    de Boer JG
    J Nutr; 2001 Nov; 131(11 Suppl):3082S-6S. PubMed ID: 11694652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of aflatoxin B1- or methyl methanesulfonate-induced chromosome aberrations in rat bone marrow cells after treatment with S-methyl methanethiosulfonate.
    Ito Y; Nakamura Y; Nakamura Y
    Mutat Res; 1997 Oct; 393(3):307-16. PubMed ID: 9393623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutagenicity an carcinogenicity of aflatoxin AFB1].
    Pierzynowska J; Grzesiuk E
    Postepy Biochem; 1999; 45(4):313-9. PubMed ID: 10786375
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity.
    Soni KB; Lahiri M; Chackradeo P; Bhide SV; Kuttan R
    Cancer Lett; 1997 May; 115(2):129-33. PubMed ID: 9149115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.